Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001477932-24-002449
Filing Date
2024-05-01
Accepted
2024-04-30 19:08:31
Documents
5
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A upxi_def14a.htm DEF 14A 349156
2 upxi_def14aimg1.jpg GRAPHIC 97363
3 upxi_def14aimg2.jpg GRAPHIC 84106
4 upxi_def14aimg3.jpg GRAPHIC 28451
5 upxi_def14aimg4.jpg GRAPHIC 28838
  Complete submission text file 0001477932-24-002449.txt   679594
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-40535 | Film No.: 24899293
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)